254
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine

, , , &
Pages 1131-1139 | Accepted 08 Mar 2011, Published online: 01 Apr 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Stephen L Able, Zhanglin Cui & Wei Shen. (2014) Duloxetine treatment adherence across mental health and chronic pain conditions. ClinicoEconomics and Outcomes Research 6, pages 75-81.
Read now
Mark Bernauer, Ning Wu, Shih-Yin Chen, Xiaomei Peng, Luke Boulanger & Yang Zhao. (2012) Use of select medications prior to duloxetine initiation among commercially-insured patients. Journal of Pain Research 5, pages 271-278.
Read now
Zhanglin Cui, Yang Zhao, Diego Novick & Douglas Faries. (2012) Predictors of duloxetine adherence and persistence in patients with fibromyalgia. Journal of Pain Research 5, pages 193-201.
Read now

Articles from other publishers (3)

Deborah Dowell, Kathleen R. Ragan, Christopher M. Jones, Grant T. Baldwin & Roger Chou. (2022) CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 . MMWR. Recommendations and Reports 71:3, pages 1-95.
Crossref
Nicole M. MarlowKit N. SimpsonIvana A. Vaughn, Ara JoJames S. ZollerEdward B. Short. (2018) Healthcare Costs and Medication Adherence Among Patients with Fibromyalgia: Combination Medication vs. Duloxetine, Milnacipran, Venlafaxine, and Pregabalin Initiators. Pain Practice 18:2, pages 154-169.
Crossref
H. Mahagna, D. Amital & H. Amital. (2016) A randomised, double‐blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia. International Journal of Clinical Practice 70:2, pages 163-170.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.